Blockade	blockade	O	O	O	O
of	of	O	O	O	O
both	both	O	O	O	O
D-1	d-1	O	O	O	O
and	and	O	O	O	O
D-2	d-2	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
receptors	receptors	O	O	O	O
may	may	O	O	O	O
induce	induce	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
mice.1	mice.1	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
antagonists	antagonists	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
tested	tested	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
possible	possible	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
subtypes	subtypes	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
determined	determined	O	O	O	O
.	.	O	O	O	O

2	2	O	O	O	O
.	.	O	O	O	O
Dopamine	dopamine	CHEMICALS	O	OTHERS	I
antagonist	antagonist	O	O	O	O
fluphenazine	fluphenazine	O	O	OTHERS	I
,	,	O	O	O	O
D-1	d-1	O	O	O	O
antagonist	antagonist	O	O	O	O
SCH	sch	CHEMICALS	O	OTHERS	I
23390	23390	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
D-2	d-2	O	O	O	O
antagonist	antagonist	O	O	O	O
sulpiride	sulpiride	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
fluphenazine	fluphenazine	O	O	OTHERS	I
and	and	O	O	O	O
sulpiride	sulpiride	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
.	.	O	O	O	O

Combination	combination	O	O	O	O
of	of	O	O	O	O
SCH	sch	CHEMICALS	O	OTHERS	I
23390	23390	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
sulpiride	sulpiride	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
induce	induce	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
potentiation	potentiation	O	O	O	O
.	.	O	O	O	O

3	3	O	O	O	O
.	.	O	O	O	O
D-1	d-1	O	O	O	O
agonist	agonist	O	O	O	O
SKF	skf	O	O	OTHERS	I
38393	38393	O	O	OTHERS	I
or	or	O	O	O	O
D-2	d-2	O	O	O	O
agonist	agonist	O	O	O	O
quinpirole	quinpirole	O	O	OTHERS	I
decreased	decreased	O	O	O	O
the	the	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
fluphenazine	fluphenazine	O	O	OTHERS	I
,	,	O	O	O	O
SCH	sch	CHEMICALS	O	OTHERS	I
23390	23390	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
sulpiride	sulpiride	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

4	4	O	O	O	O
.	.	O	O	O	O

Combination	combination	O	O	O	O
of	of	O	O	O	O
SKF	skf	O	O	OTHERS	I
38393	38393	O	O	OTHERS	I
with	with	O	O	O	O
quinpirole	quinpirole	O	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
cause	cause	O	O	O	O
potentiated	potentiated	O	O	O	O
inhibitory	inhibitory	O	O	O	O
effect	effect	O	O	O	O
on	on	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
antagonists	antagonists	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

5	5	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
data	data	O	O	O	O
may	may	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
although	although	O	O	O	O
D-2	d-2	O	O	O	O
receptor	receptor	O	O	O	O
blockade	blockade	O	O	O	O
is	is	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
D-1	d-1	O	O	O	O
receptor	receptor	O	O	O	O
may	may	O	O	O	O
plan	plan	O	O	O	O
a	a	O	O	O	O
role	role	O	O	O	O
.	.	O	O	O	O

